Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mansky

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Virology|August 15, 1996
The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr geneL M Mansky
AIDS Research and Human Retroviruses|March 1, 1996
Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell lineL M Mansky
The Journal of General Virology|June 20, 1998
Retrovirus mutation rates and their role in genetic variationL M Mansky
Virology|April 2, 2003
Mutagenic outcome of combined antiviral drug treatment during human immunodeficiency virus type 1 replicationLouis M Mansky
Viruses|July 22, 2018
The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant MutationsJosé O Maldonado, Louis M Mansky
The Journal of General Virology|July 19, 2000
In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assemblyNancy A Jewell, Louis M Mansky
Journal of Virology|March 2, 2013
Variation of HIV-1 mutation spectra among cell typesColleen M Holtz, Louis M Mansky
Cancer Research|November 1, 1973
Delayed hematological recovery after cyclophosphamide treatment in the presence of an advanced tumorW D DeWys, J M Mansky
Journal of Virology|August 1, 1995
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptaseL M Mansky, H M Temin
Journal of Virology|September 23, 2000
3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1L M Mansky, L C Bernard
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Virology|August 15, 1996
The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr geneL M Mansky
AIDS Research and Human Retroviruses|March 1, 1996
Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell lineL M Mansky
The Journal of General Virology|June 20, 1998
Retrovirus mutation rates and their role in genetic variationL M Mansky
Virology|April 2, 2003
Mutagenic outcome of combined antiviral drug treatment during human immunodeficiency virus type 1 replicationLouis M Mansky
Viruses|July 22, 2018
The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant MutationsJosé O Maldonado, Louis M Mansky
The Journal of General Virology|July 19, 2000
In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assemblyNancy A Jewell, Louis M Mansky
Journal of Virology|March 2, 2013
Variation of HIV-1 mutation spectra among cell typesColleen M Holtz, Louis M Mansky
Cancer Research|November 1, 1973
Delayed hematological recovery after cyclophosphamide treatment in the presence of an advanced tumorW D DeWys, J M Mansky
Journal of Virology|August 1, 1995
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptaseL M Mansky, H M Temin
Journal of Virology|September 23, 2000
3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1L M Mansky, L C Bernard
Pageof 13